- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-3-3-3-3-mer
 - Ligands
 - 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
 - 16 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 NAG.16: 1 residues within 4Å:- Chain G: N.603
 
Ligand excluded by PLIPNAG.17: 1 residues within 4Å:- Chain G: N.616
 
Ligand excluded by PLIPNAG.18: 3 residues within 4Å:- Chain G: H.655, V.656, N.657
 
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain G: N.709, G.1131
 - Chain I: D.796
 
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain G: A.706, E.1072, N.1074
 
Ligand excluded by PLIPNAG.21: 1 residues within 4Å:- Chain H: N.61
 
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain H: N.603, T.604
 
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain H: N.616
 
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain H: H.655, V.656, N.657
 
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain G: D.796
 - Chain H: N.709, G.1131
 
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain H: A.706, E.1072, N.1074
 
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain I: N.603, T.604
 
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain I: N.616
 
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain I: H.655, V.656, N.657
 
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain H: D.796
 - Chain I: N.709, G.1131
 
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain I: A.706, E.1072, N.1074
 
Ligand excluded by PLIP- Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Wang, N. et al., Structure-based development of human antibody cocktails against SARS-CoV-2. Cell Res. (2021)
          


 - Release Date
 - 2020-12-16
 - Peptides
 - heavy chain of FC05 Fab: ACE
light chain of FC05 Fab: BDF
Spike glycoprotein: GHI
heavy chain of P17 Fab: JLN
light chain of P17 Fab: KMO - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
PC
NE
JB
ID
GF
FG
BH
CI
AJ
HL
MN
OK
LM
RO
S 
- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-3-3-3-3-mer
 - Ligands
 - 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
 - 16 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Wang, N. et al., Structure-based development of human antibody cocktails against SARS-CoV-2. Cell Res. (2021)
          


 - Release Date
 - 2020-12-16
 - Peptides
 - heavy chain of FC05 Fab: ACE
light chain of FC05 Fab: BDF
Spike glycoprotein: GHI
heavy chain of P17 Fab: JLN
light chain of P17 Fab: KMO - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
PC
NE
JB
ID
GF
FG
BH
CI
AJ
HL
MN
OK
LM
RO
S